PTK2B and cancer: Several investigational drugs, including small molecule kinase inhibitors against FA and its homologue Pyk2 (Roberts et al, 2008), are at the stage of early clinical trials and may prove more efficient modulators of FA turnover and hence can prevent the progression of invasive cancers to metastases.